Approximately 30 min before dosing,
Emla 5% cream (AstraZeneca) was applied to the skin covering the marginal vein of an ear, and the ear was warmed via gentle stroking. After 5 min, a small incision was made across the vein with a sterile scalpel blade, and 1 mL of blood (pretreatment sample) was collected into a sterile vacutainer (
BD vacutainers, Franklin Lakes, NJ, USA) containing a clot activator (silicone-coated plastic for serum separation). Rabbits scheduled to be euthanised at 96 h were blood-sampled (post-treatment) again at 48 h.
Immediately following euthanasia (pentobarbitone injected into the marginal ear vein of the ear) or as soon as possible after death, all rabbits were blood sampled (terminal) via cardiac puncture into sterile vacutainers containing a clot activator for serum separation.
The serum was processed for biochemistry at the IDEXX-New Zealand Veterinary Pathology laboratory, Palmerston North, NZ, for the following biomarkers: aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), gamma glutamyltransferase (GGT), glutamate dehydrogenase (GDH), bilirubin, total bile acids, creatinine, amylase, lipase and creatine kinase (CK).
Collett M.G., Matthews Z.M, & Parton K.H. (2020). Hepatotoxicity of Two Progoitrin-Derived Nitriles in New Zealand White Rabbits. Toxins, 12(11), 695.